Suchergebnisse - "Scribano, Maria Lia"

PubPharm (65)

31

Safety of treatments for inflammatory bowel disease : Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2017

von Biancone, L. | Annese, V. | Ardizzone, S. | +50

32

Safety of treatments for inflammatory bowel disease: clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

enthalten in: Digestive and liver disease | 2017

von Biancone, L. | Annese, V. | Ardizzone, S. | +25

33

Corrigendum to "Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease" [Dig. Liver Dis. 48 (2016) 360-370

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2016

von Armuzzi, A. | Gionchetti, P. | Daperno, M. | +22

34

Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study

enthalten in: Journal of Crohn's & colitis | 2016

von Biancone, L. | Armuzzi, A. | Scribano, M. | +25

35

Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome

enthalten in: Journal of gastrointestinal and liver diseases : JGLD | 2016

von Portincasa, P. | Bonfrate, L. | Scribano, M. | +10

36

Randomised controlled trial of mesalazine in IBS

enthalten in: Gut | 2016

von Barbara, G. | Cremon, C. | Annese, V. | +19

CommentIn: Gut. 2016 Jan;65(1):187-8. - PMID 25873641

37

Randomised controlled trial of mesalazine in IBS

enthalten in: Gut | 2016

von Basilisco, G. | Cremon, C. | Rodi, M. | +19

38

Corrigendum to “Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease” [Dig. Liver Dis. 48 (2016) 360–370]

enthalten in: Digestive and liver disease | 2016

von Armuzzi, A. | Gionchetti, P. | Daperno, M. | +13

39

Role of Rifaximin in Inflammatory Bowel Disease Treatment

enthalten in: Mini reviews in medicinal chemistry | 2015

von Scribano, M.

40

Mucosal healing with thalidomide in refractory Crohn's disease patients intolerant of anti-TNF-α drugs : report of 3 cases and literature review

enthalten in: Journal of clinical gastroenterology | 2014

von Scribano, M. | Cantoro, L. | Marrollo, M. | +2

CommentIn: J Clin Gastroenterol. 2014 Jul;48(6):476-7. - PMID 24781387